District of New Jersey Denies Preliminary Injunction in Ustekinumab Breach of Contract Case
FDA Approves Fresenius’s Denosumab Biosimilars
FDA Accepts BLA for Alvotech and Dr. Reddy’s Denosumab Biosimilars
Celltrion Launches STEQEYMA® (ustekinumab-stba) in the United States
FDA Approves Celltrion’s Denosumab Biosimilars
Regulatory Updates on Samsung’s Denosumab Biosimilars
Regulatory and Commercial Updates on Bio-Thera’s BAT2506 (golimumab)
FDA Approves Celltrion’s AVTOZMA (tocilizumab-anoh)
Teva Announces New Biosimilar Deals
Subscribe: Subscribe via RSS
Blogs
Firm/Org